[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Respiratory Diseases in Germany 2014: Market Outlook and Emerging Opportunities

January 2014 | 283 pages | ID: 26E8BD0B5CEEN
Venture Planning Group

US$ 1,560.00 US$ 1,950.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
About This Report

This new 283-page report from Venture Planning Group presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.

In addition to market share and sales forecasts, the report:
  • Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
  • Reviews features and operating characteristics of major analyzers used for microbiology testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products; and
  • Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group's proprietary data files was conducted.

Contains 283 pages and 23 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. Adenovirus
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
    d. Adeno-Associated Viruses(AAV)
  2. Influenza Viruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  3. Legionella
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. Mononucleosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. Mycoplasma
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. Pneumonia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  7. Respiratory Syncytial Virus (RSV)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  8. Tuberculosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
Germany Respiratory Diseases
Global Market Outlook and Emerging Opportunities

LIST OF TABLES

Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests
Germany Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Influenza Testing Market Diagnostics Sales by Major Supplier
Germany Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Legionella Testing Market Diagnostics Sales by Major Supplier
Germany Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Mononucleosis Testing Market Diagnostics Sales by Major Supplier
Germany Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Mycoplasma Testing Market Diagnostics Sales by Major Supplier
Germany Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Pneumonia Testing Market Diagnostics Sales by Major Supplier
Germany RSV Test Volume and Diagnostics Sales Forecast by Market Segment
Germany RSV Testing Market Diagnostics Sales Forecast by Major Supplier
Germany Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Tuberculosis Testing Market Diagnostics Sales by Major Supplier


More Publications